Susan Mahony
CIK 1463321 · SVP & Pres., Lilly Oncology · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$63.16M
Companies
5
Total Filings
62
Lifetime Open-Market Net
-$13.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXSM | Director | 829 | $255.17 | $211.5K | -$145.0K | 7 | 2026-06-10 |
| ASMB | Director | — | $22.96 | — | $0 | 10 | 2026-06-05 |
| ZYME | Director | — | $22.88 | — | $0 | 6 | 2026-01-12 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 0 | $116.30 | $0 | $0 | 7 | 2023-10-06 |
| LLY | SVP & Pres., Lilly Oncology | 55,559 | $1133.00 | $62.95M | -$13.25M | 32 | 2019-02-01 |
Recent Filings · Page 6 of 7
62 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-01-30 | LLY | Grant (A) | +30,705 | $1.67M | EDGAR |
| 2013-11-05 | LLY | Mixed | +2,150 | -$96.0K | EDGAR |
| 2013-04-29 | LLY | Sell (S) | −3,500 | -$197.2K | EDGAR |
| 2013-03-26 | LLY | Sell (S) | −5,000 | -$280.0K | EDGAR |
| 2013-03-05 | LLY | Grant (A) | — | $0 | EDGAR |
| 2013-02-04 | LLY | Mixed | +7,166 | -$850.0K | EDGAR |
| 2013-01-29 | LLY | Grant (A) | +26,251 | $1.40M | EDGAR |
| 2012-11-07 | LLY | Sell (S) | −10,000 | -$504.5K | EDGAR |
| 2012-02-02 | LLY | Grant (A) | +1,285 | $50.7K | EDGAR |
| 2012-01-30 | LLY | Grant (A) | +4,280 | $168.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.